Patient Preferences in Hepatocellular Carcinoma Surveillance: A Multi-site Conjoint Analysis
BACKGROUND: Several emerging modalities are available for hepatocellular carcinoma (HCC) surveillance; however, patient preferences for surveillance tests - particularly across key subgroups such as race/ethnicity, income, and education level - are poorly characterized. METHODS: We conducted a choice-based conjoint survey among patients with cirrhosis and chronic hepatitis B undergoing HCC surveillance (from 2022-2024) at seven centers in the US. Participants were presented with 15 scenarios, where they chose between surveillance modalities based on test attributes. RESULTS: We included 649 patients, with a median age of 60 years, 51% male, 60% White, 10% Black, and 20% Hispanic. The cohort reflected substantial socioeconomic variation including 12% with Medicaid and 38% with Medicare. The highest priority attribute was surveillance benefits (42.9%; 95% CI: 40.6-45.1%), followed by financial harms (19.4%; 95% CI: 18.1-20.7%). Patients placed less priority on test logistics (12.3%; 95% CI: 11.5-13.2%), test location (9.2%; 95% CI: 8.5-10.0%), test duration (8.3%; 95% CI: 7.8-8.7%), and physical harms (7.9%; 95% CI: 7.2-8.6%). In subgroup analyses, Black participants placed significantly lower importance on surveillance benefits and higher importance on financial harms (p<0.001) and test duration (p=0.001) compared to White participants. Hispanic participants also prioritized financial harms more than non-Hispanic participants (p<0.001), a pattern consistent with cost-related concerns seen across other lower socioeconomic status (SES) subgroups. Lower SES individuals with below a high school education (p=0.01), Medicaid insurance (p=0.001), and income below $25,000 (p<0.001) assigned greater importance to financial harms and less to surveillance benefits. CONCLUSIONS: Patients with undergoing HCC surveillance prioritize surveillance test sensitivity; however, results vary by race, ethnicity, and SES. Improving access by reducing financial and logistical barriers through shared-decision-making may enhance surveillance, particularly when modalities present with similar effectiveness.
Authors
- Manaf Alsudaney (ORCID: https://orcid.org/0000-0003-0760-0925)
- Maarouf Hoteit (ORCID: https://orcid.org/0000-0001-6053-6884)
- Lisa Quirk (ORCID: https://orcid.org/0000-0001-8959-3815)
- Amit G. Singal (ORCID: https://orcid.org/0000-0002-1172-3971)
- Sean Woolen (ORCID: https://orcid.org/0000-0003-4951-2173)
- Neehar D. Parikh (ORCID: https://orcid.org/0000-0002-5874-9933)
- Reena Salgia (ORCID: https://orcid.org/0000-0003-0305-8673)
- Darine Daher (ORCID: https://orcid.org/0000-0002-9977-1176)
- Nishi Patel
- Karim Seif El Dahan (ORCID: https://orcid.org/0000-0003-4268-4079)
- Jonathan P. Troost (ORCID: https://orcid.org/0000-0002-1183-8330)
- Karissa D. Kao
- Prasun K. Jalal (ORCID: https://orcid.org/0000-0001-5353-2324)
- Perla Hernandez
- Neil Mehta
- Jasmine Gamez (ORCID: https://orcid.org/0009-0008-0407-2905)
- Megha Bhongade (ORCID: https://orcid.org/0009-0002-5084-1812)
- Anish Nayak (ORCID: https://orcid.org/0009-0000-2666-9632)
- Ju Dong Yang (ORCID: https://orcid.org/0000-0001-7834-9825)
Institutions
- Cedars-Sinai Medical Center (US)
- University of California, San Francisco (US)
- Baylor College of Medicine (US)
- University of Michigan (US)
- Henry Ford Hospital (US)
- University of California System (US)
- University of Pennsylvania (US)
- The University of Texas Southwestern Medical Center (US)
Publication Details
- Journal
- The American Journal of Gastroenterology
- Published
- 2026-04-10
- DOI
- https://doi.org/10.14309/ajg.0000000000004023
- Primary Topic
- Economic and Environmental Valuation
- Type
- article
- Field-Weighted Citation Impact
- 0.00